Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston
3
×
boston blog main
boston top stories
fda
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
akcea therapeutics
alnylam pharmaceuticals
clinical trials
drugs
hereditary transthyretin amyloidosis
inotersen
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
tafamidis
allopregnanolone
andrew fire
brexanolone
craig mello
european medicines agency
harvard pilgrim health care
institute for clinical and economic review
john maraganore
marc goodman
marinus pharmaceuticals
mike cloonan
nobel prize
postpartum depression
rna interference
sage therapeutics
san francisco blog main
san francisco top stories
steven kanes
svb leerink
What
drug
3
×
fda
medicine
3
×
alnylam
approved
rnai
specifically
afternoon
alnylam’s
approves
brexanolone
cells
depression
devastating
disorder
ema
employ
europe
fast
follows
gene
gets
harmful
history
hits
interference
landmark
make
making
method
moms
mute
new
ok
oks
onpattro
partum
patisiran
pharmaceuticals
post
Language
Current search:
medicine
×
drug
×
boston
×
" national top stories "
×
photo
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
6 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug